Skip to content
10-Q

Quarterly Report

PHIBRO ANIMAL HEALTH CORP PAHC

0001104659-26-010317

← back to feed
Filed
Feb 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2026 · Dec 31, 2025 40.96M sh
Shares Diluted Q2 2026 · Dec 31, 2025 40.92M sh
Shares Diluted Q2 2026 · Dec 31, 2024 40.72M sh
Shares Diluted Q2 2026 · Dec 31, 2024 40.65M sh
Dividends Paid Q2 2026 · Dec 31, 2025 $9.73M
Dividends Paid Q2 2026 · Dec 31, 2024 $9.72M
Capex Q2 2026 · Dec 31, 2025 $24.9M
Capex Q2 2026 · Dec 31, 2024 $17.41M
Operating Cash Flow Q2 2026 · Dec 31, 2025 $28.65M
Operating Cash Flow Q2 2026 · Dec 31, 2024 $15.7M
Long Term Debt Q2 2026 · Dec 31, 2025 $603.6M
Long Term Debt Q2 2026 · Jun 30, 2025 $615.44M
Short Term Investments Q2 2026 · Dec 31, 2025 $19.02M
Short Term Investments Q2 2026 · Jun 30, 2025 $9M
Cash And Equivalents Q2 2026 · Dec 31, 2025 $55.49M
Cash And Equivalents Q2 2026 · Jun 30, 2025 $68.04M
Stockholders Equity Q2 2026 · Dec 31, 2025 $332.36M
Stockholders Equity Q2 2026 · Jun 30, 2025 $285.68M
Current Liabilities Q2 2026 · Dec 31, 2025 $282.37M
Current Liabilities Q2 2026 · Jun 30, 2025 $293.47M
Total Liabilities Q2 2026 · Dec 31, 2025 $1.07B
Total Liabilities Q2 2026 · Jun 30, 2025 $1.08B
Current Assets Q2 2026 · Dec 31, 2025 $862.19M
Current Assets Q2 2026 · Jun 30, 2025 $810.61M
Total Assets Q2 2026 · Dec 31, 2025 $1.41B
Total Assets Q2 2026 · Jun 30, 2025 $1.36B
Eps Diluted Q2 2026 · Dec 31, 2025 $0.67
Eps Diluted Q2 2026 · Dec 31, 2025 $1.32
Eps Diluted Q2 2026 · Dec 31, 2024 $0.08
Eps Diluted Q2 2026 · Dec 31, 2024 $0.25
Eps Basic Q2 2026 · Dec 31, 2025 $0.68
Eps Basic Q2 2026 · Dec 31, 2025 $1.33
Eps Basic Q2 2026 · Dec 31, 2024 $0.08
Eps Basic Q2 2026 · Dec 31, 2024 $0.25
Sga Expense Q2 2026 · Dec 31, 2025 $82.33M
Sga Expense Q2 2026 · Dec 31, 2025 $150.85M
Sga Expense Q2 2026 · Dec 31, 2024 $76.34M
Sga Expense Q2 2026 · Dec 31, 2024 $142.13M
Net Income Q2 2026 · Dec 31, 2025 $27.46M
Net Income Q2 2026 · Dec 31, 2025 $53.99M
Net Income Q2 2026 · Dec 31, 2024 $3.19M
Net Income Q2 2026 · Dec 31, 2024 $10.16M
Operating Income Q2 2026 · Dec 31, 2025 $50.33M
Operating Income Q2 2026 · Dec 31, 2025 $101.59M
Operating Income Q2 2026 · Dec 31, 2024 $25.53M
Operating Income Q2 2026 · Dec 31, 2024 $43.23M
Gross Profit Q2 2026 · Dec 31, 2025 $132.66M
Gross Profit Q2 2026 · Dec 31, 2025 $252.44M
Gross Profit Q2 2026 · Dec 31, 2024 $101.87M
Gross Profit Q2 2026 · Dec 31, 2024 $185.37M
Cost Of Revenue Q2 2026 · Dec 31, 2025 $241.25M
Cost Of Revenue Q2 2026 · Dec 31, 2025 $485.36M
Cost Of Revenue Q2 2026 · Dec 31, 2024 $207.39M
Cost Of Revenue Q2 2026 · Dec 31, 2024 $384.33M
Revenue Q2 2026 · Dec 31, 2025 $373.91M
Revenue Q2 2026 · Dec 31, 2025 $737.8M
Revenue Q2 2026 · Dec 31, 2024 $309.26M
Revenue Q2 2026 · Dec 31, 2024 $569.69M